Search

Your search keyword '"Martin-Martos F."' showing total 47 results

Search Constraints

Start Over You searched for: Author "Martin-Martos F." Remove constraint Author: "Martin-Martos F."
47 results on '"Martin-Martos F."'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

8. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Timing and characteristics of venous thromboembolism after noncancer surgery

10. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

11. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

12. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

13. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

14. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

15. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

16. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

17. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

18. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

19. DVT Management and Outcome Trends, 2001 to 2014

20. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

21. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

22. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

23. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

24. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

25. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

26. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

27. Predictors of active cancer thromboembolic outcomes

28. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

29. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

30. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

31. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

32. Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry

33. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

34. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

35. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

36. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

37. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry

38. Venous thromboembolism in patients immobilised at home

39. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

40. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

41. Timing and characteristics of venous thromboembolism after noncancer surgery

42. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

43. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

44. DVT Management and Outcome Trends, 2001 to 2014

45. Platelet Count and Major Bleeding in Patients Receiving Vitamin K Antagonists for Acute Venous Thromboembolism, Findings From Real World Clinical Practice

46. A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the upper extremity

47. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

Catalog

Books, media, physical & digital resources